Vaccine for the China Virus — The Planet is the Guinea Pig for a Vast Experiment
The US National Institutes of Health (NIH) is launching a rush program to develop a vaccine against the China coronavirus.
The goal? Have a vaccine ready for human testing in an unprecedented 90 days.
NIH is partnering with a US vaccine company, Moderna, Inc.
The vaccine is a new type called RNA. According to Reuters (“With Wuhan virus genetic code in hand, scientists begin work on a vaccine,” Jan 24, 2020), “[these are] vaccines based on ribonucleic acid (RNA)—a chemical messenger that contains instructions for making proteins.”
The PHG Foundation/University of Cambridge explains further: “Unlike a normal vaccine, RNA vaccines work by introducing an mRNA sequence (the molecule which tells cells what to build) which is coded for a disease specific antigen [virus]; once produced within the body, the antigen [virus] is recognised by the immune system, preparing it to fight the real thing.”
Let’s have a look at Moderna (Twitter), the company that will be making and testing the new RNA vaccine against the China coronavirus. Its website states, in a January 23rd press release: “Moderna Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronavirus”.